UUBS OOracle · ORCL
UBS Raises Oracle Price Target to $250
Rating
Buy
Price target
$250
Previous
$245
Implied upside
+63%
UBS analyst Karl Keirstead raised the price target on Oracle (NYSE: ORCL) to $250 (from $245) while maintaining a Buy rating.
“The +4% after-market reaction in Oracle shares strikes us as reasonable given what we conclude was a quarter marked by the positives (1Q/Aug revs and EPS beat, guide for further cloud infra acceleration, completion of ATM/secondary) offsetting the negatives (no FY27 revs guide raise).
Net, the material AI-driven growth acceleration (30% revs growth from 11% a year-ago) is playing out. We remain Buy-rated.”
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
